日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

State sequence analysis of daily methadone dispensing trajectories among individuals at United States opioid treatment programs before and following COVID-19 onset

对美国阿片类药物治疗项目参与者在 COVID-19 发病前后每日美沙酮发放轨迹的状态序列分析

Bórquez, Ignacio; Williams, Arthur R; Hu, Mei-Chen; Scott, Marc; Stewart, Maureen T; Harpel, Lexa; Aydinoglo, Nicole; Cerdá, Magdalena; Rotrosen, John; Nunes, Edward V; Krawczyk, Noa

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population-based observational data

缓释纳曲酮与丁丙诺啡-纳洛酮在治疗中断方面的比较疗效:基于人群观察数据的X:BOT RCT再分析与统一目标试验模拟研究结果的比较

Lodi, Sara; Yan, Shapei; Bovell-Ammon, Benjamin; Christine, Paul J; Hsu, Heather E; Bernson, Dana; Novo, Patricia; Lee, Joshua D; Rotrosen, John; Liebschutz, Jane M; Walley, Alexander Y; Larochelle, Marc R

Effects of randomization to buprenorphine or naltrexone for OUD on cannabis use outcomes: A secondary analysis of the X:BOT trial

随机分配至丁丙诺啡或纳曲酮治疗阿片类药物使用障碍对大麻使用结果的影响:X:BOT试验的二次分析

Shulman, Matisyahu; Choo, Tse-Hwei; Ohrtman, Kaitlyn; Pavlicova, Martina; Rotrosen, John; Nunes, Edward V

Suicidal ideation in adults with opioid use disorder treated with buprenorphine-naloxone versus extended-release naltrexone

丁丙诺啡-纳洛酮与缓释纳曲酮治疗成人阿片类药物使用障碍患者的自杀意念比较

Rizk, Mina M; Stanley, Barbara; Choo, Tse-Hwei; Pavlicova, Martina; Scodes, Jennifer M; Rotrosen, John; Nunes, Edward V

Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD)

优化阿片类药物使用障碍药物治疗的维持策略:CTN-0100 试验的维持阶段 (RDD)

Shulman, Matisyahu; Meyers-Ohki, Sarah; Novo, Patricia; Provost, Scott; Ohrtman, Kaitlyn; Van Veldhuisen, Paul; Oden, Neal; Otterstatter, Michael; Bailey, Genie L; Liu, David; Rotrosen, John; Weiss, Roger D; Nunes, Edward V

A clinical trial loses access to some of its experimental treatment conditions: What can be done?

临床试验失去了一些实验性治疗条件:该怎么办?

Meyers-Ohki, Sarah; Shulman, Matisyahu; Weiss, Roger D; Novo, Patricia; Provost, Scott; Otterstatter, Michael; Bailey, Genie L; Rotrosen, John; Nunes, Edward V

Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment

阿片类药物使用障碍治疗期间复吸的个体风险预测

Luo, Sean X; Feaster, Daniel J; Liu, Ying; Balise, Raymond R; Hu, Mei-Chen; Bouzoubaa, Layla; Odom, Gabriel J; Brandt, Laura; Pan, Yue; Hser, Yih-Ing; VanVeldhuisen, Paul; Castillo, Felipe; Calderon, Anna R; Rotrosen, John; Saxon, Andrew J; Weiss, Roger D; Wall, Melanie; Nunes, Edward V

Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial

快速启动纳曲酮注射治疗阿片类药物使用障碍:一项阶梯楔形整群随机临床试验

Shulman, Matisyahu; Greiner, Miranda G; Tafessu, Hiwot M; Opara, Onumara; Ohrtman, Kaitlyn; Potter, Kenzie; Hefner, Kathryn; Jelstrom, Eve; Rosenthal, Richard N; Wenzel, Kevin; Fishman, Marc; Rotrosen, John; Ghitza, Udi E; Nunes, Edward V; Bisaga, Adam

Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder

利用观察性数据进行比较疗效研究的目标试验模拟:阿片类药物使用障碍药物研究的前景与挑战

Christine, Paul J; Lodi, Sara; Hsu, Heather E; Bovell-Ammon, Benjamin; Yan, Shapei; Bernson, Dana; Novo, Patricia; Lee, Joshua D; Rotrosen, John; Liebschutz, Jane; Walley, Alexander Y; Larochelle, Marc R

Machine Learning-Driven Analysis of Individualized Treatment Effects Comparing Buprenorphine and Naltrexone in Opioid Use Disorder Relapse Prevention

基于机器学习的个体化治疗效果分析:比较丁丙诺啡和纳曲酮在预防阿片类药物使用障碍复发中的疗效

Afshar, Majid; Graham Linck, Emma J; Spicer, Alexandra B; Rotrosen, John; Salisbury-Afshar, Elizabeth M; Sinha, Pratik; Semler, Matthew W; Churpek, Matthew M